Brief: Unity Biotechnology Considers Exposure To Liquidity Concern At SVB
13/03/2023 11:17
March 13 (Reuters) - SVB Financial Group SIVB.O :
* UNITY BIOTECHNOLOGY- CONSIDERS EXPOSURE TO LIQUIDITY
CONCERN
AT SVB AS LIMITED, GIVEN CASH HELD AT SVB IS ABOUT $2.8 MILLION
AS OF MARCH 10, 2023
Further company coverage: SIVB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Unity Biotechnology
See all newsU.S. STOCKS ON THE MOVE-Eve Holding, Magnite, EHang Holdings
U.S. STOCKS ON THE MOVE-Lamb Weston, Robinhood, Eve Holding
Unity Biotechnology slips as co faces Nasdaq delisting, plans dissolution
Brief: Unity Biotechnology Inc - Board Approves Plan Of Dissolution - SEC Filing
Brief: UNITY Biotechnology Estimates $3.7 Million Expenses For Reduction In Force